Provided by Tiger Fintech (Singapore) Pte. Ltd.

Agenus

4.05
-0.2400-5.59%
Post-market: 4.130.0800+1.98%18:38 EDT
Volume:563.44K
Turnover:2.29M
Market Cap:129.05M
PE:-0.59
High:4.26
Open:4.25
Low:4.00
Close:4.29
52wk High:7.34
52wk Low:1.38
Shares:31.86M
Float Shares:31.33M
Volume Ratio:0.98
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.8275
EPS(LYR):-10.5913
ROE:-1278.83%
ROA:-23.93%
PB:-0.36
PE(LYR):-0.38

Loading ...

Promising Clinical Trial Results Support Buy Rating for Agenus’s Botensilimab and Balstilimab Therapy

TIPRANKS
·
Oct 17

Agenus Reports 39% Two-Year Survival with BOT/BAL Immunotherapy Across Multiple Refractory Solid Tumors at ESMO 2025

Reuters
·
Oct 17

Agenus Reports 39% of Patients Alive at Two-Years With BOT/Bal Across Multiple Refractory Solid Tumors at Esmo 2025

THOMSON REUTERS
·
Oct 17

Agenus Secures 10 Million Loan from Zydus Backed by MiNK Therapeutics Shares

Reuters
·
Oct 10

BRIEF-Agenus - Closing Of Deals With Zydus Pharmaceuticals - SEC Filing

Reuters
·
Sep 24

Agenus Faces CFIUS Review Delay in Zydus Deal

TIPRANKS
·
Sep 24

Agenus Inc - Closing of Deals With Zydus Pharmaceuticals (USA) Shifted to Q4 2025 - SEC Filing

THOMSON REUTERS
·
Sep 24

Agenus Inc. and Zydus Pharmaceuticals Delay Transaction Closure to Q4 2025 Following CFIUS Review Request

Reuters
·
Sep 24

Agenus Price Target Maintained With a $23.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 10

BRIEF-France Authorizes Reimbursed Compassionate Use of Agenus’ BOT/BAL for MSS Metastatic Colorectal Cancer

Reuters
·
Sep 09

Agenus: France Grants Reimbursed Compassionate Access for Agenus' BOT/Bal in Refractory Mss Metastatic Colorectal Cancer

THOMSON REUTERS
·
Sep 09

Agenus Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference in New York City

Reuters
·
Sep 05

Agenus Price Target Maintained With a $23.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 28

Agenus Inc. Announces Strategic Advancements and Key Milestones in Immuno-Oncology at Upcoming Virtual Stakeholder Briefing

Reuters
·
Aug 19

Agenus Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 12

Agenus Q2 EPS $(1.00) Misses $0.58 Estimate, Sales $25.700M Miss $49.710M Estimate

Benzinga
·
Aug 11

Agenus Inc. Schedules Virtual Meeting on August 27th to Discuss Q2 2025 Financial Results and Strategic Progress

Reuters
·
Aug 11

Agenus Announces - Q2 Loss per Share $1.00

THOMSON REUTERS
·
Aug 11

Agenus Announces - Q2 Revenue, Including Non-Cash Royalties $25.7 Mln

THOMSON REUTERS
·
Aug 11

Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

THOMSON REUTERS
·
Aug 11